JUNGLA

Our genetic uniqueness presents challenges to clinical care. Despite remarkable advances in genomics, much less than 1% of the genetic variants in the population are clinically understood. The resulting uncertainty in interpretation poses significant challenges for both molecular diagnostic and screening tests, as well as for tests that seek to guide therapeutic interventions. Jungla develops solutions that allow us to look deeper into our genomes... To overcome these gaps, Jungla continuously integrates and enhances clinical knowledge with auditable functional and computational evidence in each gene and disease.

Also known as: Jungla Inc.

Primary location: South San Francisco United States